| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -23,150 | 100% | $0.0174 | -$403 |
| Net | -1 | -23,150 | -100% | -$403 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marilyn Elson | 10%+ Owner | $1,460,445 | -$403 | -0.03% | 10 Sep 2025 |
| Leonard Osser | 10%+ Owner | $1,311,047 | 29 Sep 2025 | ||
| Ben Hu | Director | $305,446 | 19 Dec 2025 | ||
| Rick Morad | Director | $190,541 | 16 Sep 2022 | ||
| David Owens | Chief Medical Officer, Director | $154,914 | 19 Dec 2025 | ||
| Alan Kazden | Director | $96,867 | 19 Dec 2025 | ||
| Carolyn Hamby Shelton | Sr. VP - Quality - Regulatory | $66,000 | 19 Dec 2025 | ||
| Leslie Bernhard | Director | $47,346 | 30 Sep 2024 | ||
| Justin van Fleet | Cfo | $24,750 | 19 Dec 2025 | ||
| Mark White | CEO, Director | 19 Dec 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark White | NXL | Stock Option (right to buy)* | Award | 72.1% | 1,000,000 | 2,387,024 | 19 Dec 2025 | Direct | ||
| Justin van Fleet | NXL | Stock Option (right to buy)* | Award | 76.7% | 100,000 | 230,435 | 19 Dec 2025 | Direct | ||
| David Owens | NXL | Stock Option (right to buy)* | Award | 67.4% | 1,000,000 | 2,484,809 | 19 Dec 2025 | Direct | ||
| Carolyn Hamby Shelton | NXL | Stock Option (right to buy)* | Award | 90.4% | 100,000 | 210,620 | 19 Dec 2025 | Direct | ||
| Ben Hu | NXL | Stock Option (right to buy)* | Award | 100,000 | 100,000 | 19 Dec 2025 | Direct | |||
| Alan Kazden | NXL | Stock Option (right to buy)* | Award | 38.1% | 100,000 | 362,500 | 19 Dec 2025 | Direct | ||
| Leonard Osser | NXL | Common Stock | Award | 5.43% | 83,333 | 1,618,577 | 29 Sep 2025 | Direct | ||
| David Owens | NXL | Common stock | Award | 23.6% | 36,459 | 191,252 | 29 Sep 2025 | Direct | ||
| Ben Hu | NXL | Common stock | Award | 10.7% | 36,459 | 377,095 | 29 Sep 2025 | Direct | ||
| Alan Kazden | NXL | Common stock | Award | 43.9% | 36,459 | 119,590 | 29 Sep 2025 | Owned by Alan and Natalie Kazden Family Trust | ||
| Carolyn Hamby Shelton | NXL | Stock Option (right to buy) | Award | 22.1% | 20,000 | 110,620 | 12 Sep 2025 | Direct | ||
| David Owens | NXL | Stock Option (right to buy) | Award | 25.6% | 303,125 | 1,484,809 | 12 Sep 2025 | Direct | ||
| Marilyn Elson | NXL | Common Stock Warrants | Sale | -17% | -23,150 | 112,850 | 10 Sep 2025 | Direct | ||
| Marilyn Elson. | NXL | Stock Option (right to buy) | Award | 220.6% | 300,000 | 436,000 | 17 Jul 2025 | Direct |